TissueScan, Prostate Cancer cDNA Array I

SKU
HPRT301
TissueScan Prostate Cancer Tissue qPCR Panel I (5) containing five identical sets of 48 tissues covering four disease stages, BPH and normal tissues
  $1,870.00
In Stock*
Specifications
Specifications
Product Data
TissueScan Type Cancer Specific
Array Name Prostate Cancer cDNA Array I
Clinical Info
Diagnosis Category Prostate Cancer
Tissue Prostate
Shipping Ambient
Description TissueScan Prostate Cancer Tissue qPCR Panel I (5) containing five identical sets of 48 tissues covering four disease stages, BPH and normal tissues
Reviews
 
 
 
 
 

Be the first to review this product

Please note:
Only reviews with images are eligible for a $20/20€ Amazon gift card.
Reviews without images are eligible for a $10/10€ Amazon gift card.
For more details about the terms and conditions, please visit the promotion page.

Review image
Documents
Resources

file-alt Citations

Thyroid hormone and androgen signals mutually interplay and enhance inflammation and tumorigenic activation of tumor microenvironment in prostate cancer
Miro, Di Giovanni, Murolo et al
Cancer Lett (2022) 532, 215581 DOI: 10.1016/j.canlet.2022.215581
Cited by 75
AI Summary: OriGene’s TissueScan Prostate Cancer Tissue qPCR Arrays Panel I (Cat. HPRT301) was used in this study to analyze gene expression profiles across prostate cancer tissue samples, helping to elucidate the interplay between thyroid hormone and androgen signaling in prostate cancer progression.
Snippet: we used a TissueScan Prostate Cancer Tissue qPCR Arrays Panel I (OriGene Technologies Inc., Rockville, USA;Cat. HPRT301),
A Panel of Biomarkers for Diagnosis of Prostate Cancer Using Urine Samples
Guo, Yang, Zhang et al
Anticancer Res. (2018) 38 (3), 1471-1477 DOI: 10.21873/anticanres.12373
AI Summary: OriGene’s TissueScan Prostate Tissue qPCR Array was used to measure gene-expression levels of 35 biomarkers in prostate specimens, enabling the identification of the six-biomarker panel evaluated in this study for prostate cancer diagnosis using urine samples.
Snippet: Previously, gene-expression levels of 35 biomarkers were measured in a cohort of 144 patient prostate specimens from TissueScan Prostate Tissue qPCR Array (OriGene Technologies, Rockville, MD, USA) as described elsewhere (9). Among them, six biomarkers
A FTH1 gene:pseudogene:microRNA network regulates tumorigenesis in prostate cancer
Chan, Kwok, Chew et al
Nucleic Acids Res. (2017)
AI Summary: OriGene provided normal and prostate cancer tissue RNA samples used in this study to analyze the FTH1 gene:pseudogene:microRNA network’s role in prostate cancer tumorigenesis.
Snippet: Puro vector (Addgene);normal and PCa tissue RNA samples (Origene). Plasmids and mutagenesis Oligonucleotides for specific MREs were annealed by heat- ing at 95 ◦ C for 5 min and cooled gradually to room tem- perature
Showing 1-3 of 3 papers.
Powered by BizGenius
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.

Related Products